Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boill Healthcare Holdings is a Hong Kong-listed investment holding company whose operations span foundation piling, property development, property management, securities investment, and healthcare-related real estate and elderly care/leisure services. Despite the word "Healthcare" in its name, the company is not a biotech or drug-development company and does not appear to operate a therapeutic pipeline. Its healthcare exposure is primarily through development and operation of healthcare-related properties and health resort or eldercare-oriented assets. The company was formerly known as Ngai Shun Holdings and adopted the Boill Healthcare Holdings name in 2017. As of 2024-2026, the company remained listed in Hong Kong but its shares were suspended from trading and it faced delisting-related review proceedings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boill Healthcare Holdings.